149 related articles for article (PubMed ID: 17148732)
1. Metabolic syndrome manifestations in classic congenital adrenal hyperplasia: do they predispose to atherosclerotic cardiovascular disease and secondary polycystic ovary syndrome?
Charmandari E; Chrousos GP
Ann N Y Acad Sci; 2006 Nov; 1083():37-53. PubMed ID: 17148732
[TBL] [Abstract][Full Text] [Related]
2. Congenital adrenal hyperplasia due to 21-hydroxylase deficiency - management in adults.
Ambroziak U; Bednarczuk T; Ginalska-Malinowska M; Małunowicz EM; Grzechocińska B; Kamiński P; Bablok L; Przedlacki J; Bar-Andziak E
Endokrynol Pol; 2010; 61(1):142-55. PubMed ID: 20205117
[TBL] [Abstract][Full Text] [Related]
3. [Congenital adrenal hyperplasia due to 21-hydroxylase deficiency--management in adults].
Ambroziak U; Bednarczuk T; Ginalska-Malinowska M; Małunowicz EM; Grzechocińska B; Kamiński P; Bablok L; Przedlacki J; Bar-Andziak E
Endokrynol Pol; 2010; 61 Suppl 1():7-21. PubMed ID: 22127631
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular disease risk in adult women with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Kim MS; Merke DP
Semin Reprod Med; 2009 Jul; 27(4):316-21. PubMed ID: 19530065
[TBL] [Abstract][Full Text] [Related]
5. NIH conference. Future directions in the study and management of congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Merke DP; Bornstein SR; Avila NA; Chrousos GP
Ann Intern Med; 2002 Feb; 136(4):320-34. PubMed ID: 11848730
[TBL] [Abstract][Full Text] [Related]
6. Children with classic congenital adrenal hyperplasia have elevated serum leptin concentrations and insulin resistance: potential clinical implications.
Charmandari E; Weise M; Bornstein SR; Eisenhofer G; Keil MF; Chrousos GP; Merke DP
J Clin Endocrinol Metab; 2002 May; 87(5):2114-20. PubMed ID: 11994350
[TBL] [Abstract][Full Text] [Related]
7. [Polycystic ovary syndrome of extra-ovarian origin. Review].
Terán Dávila J; Teppa-Garrán AD
Invest Clin; 2001 Mar; 42(1):51-78. PubMed ID: 11294032
[TBL] [Abstract][Full Text] [Related]
8. Classic congenital adrenal hyperplasia and puberty.
Charmandari E; Brook CG; Hindmarsh PC
Eur J Endocrinol; 2004 Nov; 151 Suppl 3():U77-82. PubMed ID: 15554890
[TBL] [Abstract][Full Text] [Related]
9. Cardio-metabolic risk factors in youth with classical 21-hydroxylase deficiency.
Ariyawatkul K; Tepmongkol S; Aroonparkmongkol S; Sahakitrungruang T
Eur J Pediatr; 2017 Apr; 176(4):537-545. PubMed ID: 28224294
[TBL] [Abstract][Full Text] [Related]
10. Metabolic disorders in newly diagnosed young adult female patients with simple virilizing 21-hydroxylase deficiency.
Zhang HJ; Yang J; Zhang MN; Liu CQ; Xu M; Li XJ; Yang SY; Li XY
Endocrine; 2010 Oct; 38(2):260-5. PubMed ID: 20978868
[TBL] [Abstract][Full Text] [Related]
11. Polycystic ovarian disease and congenital and late-onset adrenal hyperplasia.
New MI
Endocrinol Metab Clin North Am; 1988 Dec; 17(4):637-48. PubMed ID: 3058471
[TBL] [Abstract][Full Text] [Related]
12. Classical forms of congenital adrenal hyperplasia due to 21-hydroxylase deficiency in adults.
Bachelot A; Chakthoura Z; Rouxel A; Dulon J; Touraine P
Horm Res; 2008; 69(4):203-11. PubMed ID: 18204267
[TBL] [Abstract][Full Text] [Related]
13. Cardiovascular Disease Risk Factors and Metabolic Morbidity in a Longitudinal Study of Congenital Adrenal Hyperplasia.
Torky A; Sinaii N; Jha S; Desai J; El-Maouche D; Mallappa A; Merke DP
J Clin Endocrinol Metab; 2021 Nov; 106(12):e5247-e5257. PubMed ID: 33677504
[TBL] [Abstract][Full Text] [Related]
14. Polycystic Ovary Syndrome and NC-CAH: Distinct Characteristics and Common Findings. A Systematic Review.
Papadakis G; Kandaraki EA; Tseniklidi E; Papalou O; Diamanti-Kandarakis E
Front Endocrinol (Lausanne); 2019; 10():388. PubMed ID: 31275245
[No Abstract] [Full Text] [Related]
15. Normal ovarian structure and function with normal glucose tolerance in girls with early treatment of classic congenital adrenal hyperplasia.
Fleischman A; Paltiel H; Chow J; Ringelheim J; Gordon CM
J Pediatr Adolesc Gynecol; 2007 Apr; 20(2):67-72. PubMed ID: 17418389
[TBL] [Abstract][Full Text] [Related]
16. Congenital adrenal hyperplasia.
Merke DP; Bornstein SR
Lancet; 2005 Jun 18-24; 365(9477):2125-36. PubMed ID: 15964450
[TBL] [Abstract][Full Text] [Related]
17. 21-hydroxylase-deficient nonclassic adrenal hyperplasia: the great pretender.
Moran C; Azziz R
Semin Reprod Med; 2003 Aug; 21(3):295-300. PubMed ID: 14593552
[TBL] [Abstract][Full Text] [Related]
18. Components of Metabolic Syndrome in Youth With Classical Congenital Adrenal Hyperplasia.
Kim MS; Fraga NR; Minaeian N; Geffner ME
Front Endocrinol (Lausanne); 2022; 13():848274. PubMed ID: 35399922
[TBL] [Abstract][Full Text] [Related]
19. Role of obesity and adiposity in polycystic ovary syndrome.
Diamanti-Kandarakis E
Int J Obes (Lond); 2007 Nov; 31 Suppl 2():S8-13; discussion S31-2. PubMed ID: 17968437
[TBL] [Abstract][Full Text] [Related]
20. Polycystic ovary syndrome in the Indian Subcontinent.
Allahbadia GN; Merchant R
Semin Reprod Med; 2008 Jan; 26(1):22-34. PubMed ID: 18181079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
